Changing the paradigms for the treatment of chronic kidney disease

Daniel W. Coyne; Csaba P. Kovesdy

doi:10.1016/j.kisu.2017.09.003

Changing the paradigms for the treatment of chronic kidney disease

Daniel W. Coyne
, Csaba P. Kovesdy

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	155-156
Number of pages	2
Journal	Kidney International Supplements
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/j.kisu.2017.09.003
State	Published - Dec 2017

Access to Document

10.1016/j.kisu.2017.09.003

Cite this

@article{fababdd97684492997d267f64c125184,

title = "Changing the paradigms for the treatment of chronic kidney disease",

author = "Coyne, \{Daniel W.\} and Kovesdy, \{Csaba P.\}",

note = "Funding Information: Publication of this article was supported by AstraZeneca and FibroGen. This supplement summarizes the two continuing medical education meetings held during the International Society of Nephrology/World Congress of Nephrology conference. The two educational meetings were supported by an educational grant from FibroGen and AstraZeneca. FibroGen and AstraZeneca had no involvement in the development of the two continuing medical education meetings or this supplement. The Med Ed Group, Inc, the meeting organizers, provided editorial support for this supplement. SynAptiv accredited the two continuing medical education meetings and has reviewed this supplement.",

year = "2017",

month = dec,

doi = "10.1016/j.kisu.2017.09.003",

language = "English",

volume = "7",

pages = "155--156",

journal = "Kidney International Supplements",

issn = "2157-1724",

number = "3",

}

TY - JOUR

T1 - Changing the paradigms for the treatment of chronic kidney disease

AU - Coyne, Daniel W.

AU - Kovesdy, Csaba P.

N1 - Funding Information: Publication of this article was supported by AstraZeneca and FibroGen. This supplement summarizes the two continuing medical education meetings held during the International Society of Nephrology/World Congress of Nephrology conference. The two educational meetings were supported by an educational grant from FibroGen and AstraZeneca. FibroGen and AstraZeneca had no involvement in the development of the two continuing medical education meetings or this supplement. The Med Ed Group, Inc, the meeting organizers, provided editorial support for this supplement. SynAptiv accredited the two continuing medical education meetings and has reviewed this supplement.

PY - 2017/12

Y1 - 2017/12

UR - https://www.scopus.com/pages/publications/85035764839

U2 - 10.1016/j.kisu.2017.09.003

DO - 10.1016/j.kisu.2017.09.003

M3 - Comment/debate

AN - SCOPUS:85035764839

SN - 2157-1724

VL - 7

SP - 155

EP - 156

JO - Kidney International Supplements

JF - Kidney International Supplements

IS - 3

ER -

Changing the paradigms for the treatment of chronic kidney disease

Access to Document

Other files and links

Cite this